Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients.

BMC Nephrology
Yu Bum ChoiHyung Jong Kim

Abstract

Although the soluble form of suppression of tumorigenicity 2 (sST2) and soluble low-density lipoprotein receptor relative with 11 ligand-binding repeats (sLR11) have emerged as novel cardiovascular biomarkers in patients with cardiovascular disease, their prognostic value has not been fully investigated in peritoneal dialysis (PD) patients. We included 74 prevalent PD patients from a prospective cohort and measured serum sST2 and sLR11 concentrations by an enzyme-linked immunosorbent assay. The association of these biomarkers and all-cause mortality and major adverse cardiac and cerebrovascular events (MACCEs) was evaluated. During a follow-up of 38.5 months, all-cause deaths and MACCEs were observed in 13 (17.6%) patients and 23 (31.3%) patients. Multivariable Cox analyses demonstrated that greater sST2 was independently associated with higher risk of all-cause mortality (≥75.8 ng/mL; hazard ratio [HR] = 5.551; 95% confidence interval [CI] = 1.360-22.660) and MACCEs (≥72.5 ng/mL; HR = 4.609; 95% CI = 1.608-13.208). Furthermore, sST2 showed additive predictive value for mortality to the base model including traditional risk factors (net reclassification index = 0.598, P = 0.04). sLR11 was not significantly associated with all-c...Continue Reading

References

Nov 13, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·T KanakiY Saito
Oct 2, 2008·Nature Reviews. Drug Discovery·Rahul Kakkar, Richard T Lee
Jan 6, 2010·Atherosclerosis·Mao TakahashiKohji Shirai
Jan 22, 2010·Nephron. Clinical Practice·Roberto Pecoits-Filho, Silvio H Barberato
Feb 2, 2010·Journal of the American College of Cardiology·Robin A P WeirJohn J V McMurray
Mar 17, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andrew A HouseUNKNOWN Acute Dialysis Quality Initiative Consensus Group
Nov 7, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Manabu OgitaHiroyuki Daida
Nov 23, 2013·Journal of Cardiac Failure·Antoni Bayes-GenisJosep Lupón
Oct 11, 2014·Future Cardiology·Lori B Daniels, Antoni Bayes-Genis
Feb 16, 2015·The American Journal of Cardiology·Alan S MaiselChristian Mueller
Dec 20, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jing ChenUNKNOWN CRIC Study Investigators
Dec 10, 2017·Clinica Chimica Acta; International Journal of Clinical Chemistry·Evgenija Homsak, Robert Ekart
Apr 10, 2018·Kidney Research and Clinical Practice·Dong-Chan JinYong-Kyun Kim
Jun 6, 2018·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Courtney TuegelNisha Bansal

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
enzyme-linked immunosorbent assay

Software Mentioned

R
R Foundation for
PD Adequest
SPSS

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.